14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The PIDDosome activates p53 in response to supernumerary centrosomes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this study, Fava et al. show that an increase in the number of mature centrosomes (the main microtubule-organizing centers in animal cells), generated by disrupting cytokinesis or forcing centrosome overduplication, triggers the activation of the PIDDosome multiprotein complex, leading to Caspase-2-mediated MDM2 cleavage, p53 stabilization, and p21-dependent cell cycle arrest.

          Abstract

          Centrosomes, the main microtubule-organizing centers in animal cells, are replicated exactly once during the cell division cycle to form the poles of the mitotic spindle. Supernumerary centrosomes can lead to aberrant cell division and have been causally linked to chromosomal instability and cancer. Here, we report that an increase in the number of mature centrosomes, generated by disrupting cytokinesis or forcing centrosome overduplication, triggers the activation of the PIDDosome multiprotein complex, leading to Caspase-2-mediated MDM2 cleavage, p53 stabilization, and p21-dependent cell cycle arrest. This pathway also restrains the extent of developmentally scheduled polyploidization by regulating p53 levels in hepatocytes during liver organogenesis. Taken together, the PIDDosome acts as a first barrier, engaging p53 to halt the proliferation of cells carrying more than one mature centrosome to maintain genome integrity.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: not found
          • Article: not found

          Improved vectors and genome-wide libraries for CRISPR screening.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pan-cancer patterns of somatic copy-number alteration

            Determining how somatic copy-number alterations (SCNAs) promote cancer is an important goal. We characterized SCNA patterns among 4934 cancers from The Cancer Genome Atlas Pan-Cancer dataset. Whole-genome doubling, observed in 37% of cancers, was associated with higher rates of every other type of SCNA, TP53 mutations, CCNE1 amplifications, and alterations of the PPP2R complex. SCNAs that were internal to chromosomes tended to be shorter than telomere-bounded SCNAs, suggesting different mechanisms of generation. Significantly recurrent focal SCNAs were observed in 140 regions, including 102 without known oncogene or tumor suppressor gene targets and 50 with significantly mutated genes. Amplified regions without known oncogenes are enriched for genes involved in epigenetic regulation. When levels of genomic disruption were accounted for, 7% of region pairs anticorrelated, and these tended to encompass genes whose proteins physically interact, suggesting related functions. These results provide insights into mechanisms of generation and functional consequences of cancer SCNAs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis.

              The mitotic checkpoint is a major cell cycle control mechanism that guards against chromosome missegregation and the subsequent production of aneuploid daughter cells. Most cancer cells are aneuploid and frequently missegregate chromosomes during mitosis. Indeed, aneuploidy is a common characteristic of tumours, and, for over 100 years, it has been proposed to drive tumour progression. However, recent evidence has revealed that although aneuploidy can increase the potential for cellular transformation, it also acts to antagonize tumorigenesis in certain genetic contexts. A clearer understanding of the tumour suppressive function of aneuploidy might reveal new avenues for anticancer therapy.
                Bookmark

                Author and article information

                Journal
                Genes Dev
                Genes Dev
                genesdev
                genesdev
                GAD
                Genes & Development
                Cold Spring Harbor Laboratory Press
                0890-9369
                1549-5477
                1 January 2017
                1 January 2017
                : 31
                : 1
                : 34-45
                Affiliations
                [1 ]Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria;
                [2 ]Department of Internal Medicine VI, Infectious Diseases, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, 6020 Innsbruck, Austria;
                [3 ]Division of Molecular Pathophysiology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria;
                [4 ]Biozentrum, University of Basel, 4056 Basel, Switzerland;
                [5 ]Tyrolean Cancer Research Institute, 6020 Innsbruck, Austria
                Author notes
                [6]

                These authors contributed equally to this work.

                Article
                8711660
                10.1101/gad.289728.116
                5287111
                28130345
                caacb80d-a0a5-4d23-8703-06cfa8936194
                © 2017 Fava et al.; Published by Cold Spring Harbor Laboratory Press

                This article, published in Genes & Development, is available under a Creative Commons License (Attribution 4.0 International), as described at http://creativecommons.org/licenses/by/4.0/.

                History
                : 24 August 2016
                : 15 December 2016
                Page count
                Pages: 12
                Funding
                Funded by: Austrian Science Fund http://dx.doi.org/10.13039/501100002428
                Award ID: P-26856
                Funded by: Molecular Cell Biology and Oncology Post-Graduate Program
                Award ID: W1101
                Funded by: Intramural Funding Program
                Funded by: Medical University of Innsbruck
                Award ID: 2014-05-026
                Funded by: Swiss National Science Foundation
                Award ID: 310030B_149641
                Categories
                Research Paper

                cell division,centrosome,cytokinesis failure,p53
                cell division, centrosome, cytokinesis failure, p53

                Comments

                Comment on this article